In this section you will find the list of Clinical Practice Guidelines (CPGs) and other Clinical Decision Making Tools (CDMTs) compiled and classified on Quality Domains. Please go to Guidelines and other CDMTs Section to see the methodology followed.
*Please note that classification for CPGs and other CDMTs on Bleeding and Coagulation disorders and Lymphoid malignances on Quality Domains is ongoing. Documents will be searchable soon.
Subnetwork: Myeloid malignancies
Disease group/s: Myelodysplastic syndrome
Scope and Purpose: 5. Diagnosis and treatment
Patients' involvement?: No
Rigour of development: A - Evidence and consensus based
Subnetwork: Myeloid malignancies
Disease group/s: Myelofibrosis
Scope and Purpose: 3. Treatment
Patients' involvement?: No
Rigour of development: A - Evidence and consensus based
Subnetwork: Myeloid malignancies
Disease group/s: Myeloproliferative neoplasm
Scope and Purpose: 5. Diagnosis and treatment
Patients' involvement?: No
Rigour of development: A - Evidence and consensus based
Link: https://www.ncbi.nlm.nih.gov/pubmed/28982745
Comment:
Version 2.2018.
Subnetwork: Myeloid malignancies
Disease group/s: Transversal
Scope and Purpose: 2. Diagnosis
Patients' involvement?: No
Rigour of development: A - Evidence and consensus based
Link: https://www.ncbi.nlm.nih.gov/pubmed/26922887
Comment:
Project aimed at harmonizing diagnostic protocols adopting the highest quality experimental methodology. Current methodology assessment scale not applicable.
Subnetwork: Myeloid malignancies
Disease group/s: Transversal
Scope and Purpose: 6. Prevention, diagnosis, treatment
Patients' involvement?: No
Rigour of development: A - Evidence and consensus based
Subnetwork: Myeloid malignancies
Disease group/s: Transversal
Scope and Purpose: 3. Treatment
Patients' involvement?: No
Rigour of development: A - Evidence and consensus based
Subnetwork: Myeloid malignancies
Disease group/s: Transversal
Scope and Purpose: 1. Prevention
Patients' involvement?: No
Rigour of development: A - Evidence and consensus based
Subnetwork: Myeloid malignancies
Disease group/s: Transversal
Scope and Purpose: 2. Diagnosis
Patients' involvement?: No
Rigour of development: A - Evidence and consensus based
Subnetwork: Myeloid malignancies
Disease group/s: Transversal
Scope and Purpose: 6. Prevention, diagnosis, treatment
Patients' involvement?: No
Rigour of development: A - Evidence and consensus based
Subnetwork: Myeloid malignancies
Disease group/s: Transversal
Scope and Purpose: 6. Prevention, diagnosis, treatment
Patients' involvement?: No
Rigour of development: A - Evidence and consensus based
Subnetwork: Myeloid malignancies
Disease group/s: Transversal
Scope and Purpose: 6. Prevention, diagnosis, treatment
Patients' involvement?: No
Rigour of development: A - Evidence and consensus based
Subnetwork: Myeloid malignancies
Disease group/s: Transversal
Scope and Purpose: 1. Prevention
Patients' involvement?: No
Rigour of development: A - Evidence and consensus based
Subnetwork: Myeloid malignancies
Disease group/s: Transversal
Scope and Purpose: 3. Treatment
Patients' involvement?: No
Rigour of development: A - Evidence and consensus based
Subnetwork: Myeloid malignancies
Disease group/s: Chronic myelomonocytic leukemia, Myelodysplastic syndrome
Scope and Purpose: 3. Treatment
Patients' involvement?: No
Rigour of development: A - Evidence and consensus based
Subnetwork: Myeloid malignancies
Disease group/s: Acute myeloid leukemia (AML)
Scope and Purpose: 5. Diagnosis and treatment
Patients' involvement?: No
Rigour of development: B - Consensus based
Subnetwork: Myeloid malignancies
Disease group/s: Acute myeloid leukemia (AML)
Scope and Purpose: 2. Diagnosis
Patients' involvement?: No
Rigour of development: B - Consensus based
Subnetwork: Myeloid malignancies
Disease group/s: Acute promyelocytic leukemia
Scope and Purpose: 5. Diagnosis and treatment
Patients' involvement?: No
Rigour of development: B - Consensus based
Subnetwork: Myeloid malignancies
Disease group/s: Chronic myeloid leukemia
Scope and Purpose: 5. Diagnosis and treatment
Patients' involvement?: No
Rigour of development: B - Consensus based
Link: https://www.ncbi.nlm.nih.gov/pubmed/23803709
Comment:
Ed. 2013. Systematic review of the literature but no grading system for strength of recommendation
Subnetwork: Myeloid malignancies
Disease group/s: Chronic myeloid leukemia
Scope and Purpose: 5. Diagnosis and treatment
Patients' involvement?: No
Rigour of development: B - Consensus based
Link: https://www.ncbi.nlm.nih.gov/pubmed/27121688
Comment:
Systematic review of the literature but no grading system for strength of recommendation
Subnetwork: Myeloid malignancies
Disease group/s: Myeloproliferative neoplasm
Scope and Purpose: 2. Diagnosis
Patients' involvement?: No
Rigour of development: B - Consensus based
Subnetwork: Myeloid malignancies
Disease group/s: Transversal
Scope and Purpose: 2. Diagnosis
Patients' involvement?: No
Rigour of development: B - Consensus based
Subnetwork: Myeloid malignancies
Disease group/s: Myelofibrosis, Myeloproliferative neoplasm
Scope and Purpose: 2. Diagnosis
Patients' involvement?: No
Rigour of development: B - Consensus based
Subnetwork: Myeloid malignancies
Disease group/s: Myelofibrosis, Myeloproliferative neoplasm
Scope and Purpose: 5. Diagnosis and treatment
Patients' involvement?: No
Rigour of development: B - Consensus based
Link: https://www.ncbi.nlm.nih.gov/pubmed/21205761
Comment:
Systematic review of the literature but no grading system for strength of recommendation
Subnetwork: Myeloid malignancies
Disease group/s: Chronic myelomonocytic leukemia, Myelodysplastic syndrome, Myelodysplastic/myeloproliferative disease, Myeloproliferative neoplasm
Scope and Purpose: 2. Diagnosis
Patients' involvement?: No
Rigour of development: B - Consensus based
Subnetwork: Myeloid malignancies
Disease group/s: Mastocytosis
Scope and Purpose: 5. Diagnosis and treatment
Patients' involvement?: No
Rigour of development: C - Expert opinion
Subnetwork: Myeloid malignancies
Disease group/s: Transversal
Scope and Purpose: 6. Prevention, diagnosis, treatment
Patients' involvement?: No
Rigour of development: C - Expert opinion
Link: https://www.ncbi.nlm.nih.gov/pubmed/27892949
Comment:
Survey aimed at evaluating how effectively the information in the recommendations had reached the centres, studying the attitudes of the centres and the impact of the recommendations on centre policies.
